Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yves Fradet

Showing results (81-90 of 240) with videos related to

Pageof 24
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 1, 2014
Steroidogenic germline polymorphism predictors of prostate cancer progression in the estradiol pathwayEric Lévesque, Isabelle Laverdière, Etienne Audet-Walsh, et al.
Endocrine-Related Cancer|December 3, 2014
The UGT1 locus is a determinant of prostate cancer recurrence after prostatectomyIsabelle Laverdière, Christine Flageole, Étienne Audet-Walsh, et al.
The Prostate|January 27, 2004
Expression of p21 cell cycle protein is an independent predictor of response to salvage radiotherapy after radical prostatectomyJérôme Rigaud, Rabi Tiguert, Marc Decobert, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 5, 2008
Intravesical chemotherapy of high-grade bladder cancer with HTI-286, a synthetic analogue of the marine sponge product hemiasterlinBoris A Hadaschik, Hans Adomat, Ladan Fazli, et al.
European Urology|February 6, 2009
Bladder tumor infiltrating mature dendritic cells and macrophages as predictors of response to bacillus Calmette-Guérin immunotherapyCherifa Ayari, Hélène LaRue, Hélène Hovington, et al.
European Urology Focus|July 30, 2017
Metabolic Imaging of Prostate Cancer Reveals Intrapatient Intermetastasis Response Heterogeneity to Systemic TherapyFannie Morin, Jean-Mathieu Beauregard, Michelle Bergeron, et al.
European Urology|February 3, 2007
Tamoxifen as prophylaxis for prevention of gynaecomastia and breast pain associated with bicalutamide 150 mg monotherapy in patients with prostate cancer: a randomised, placebo-controlled, dose-response studyYves Fradet, Blair Egerdie, Morten Andersen, et al.
The Journal of Urology|May 15, 2007
A phase III, multicenter comparison of hexaminolevulinate fluorescence cystoscopy and white light cystoscopy for the detection of superficial papillary lesions in patients with bladder cancerH Barton Grossman, Leonard Gomella, Yves Fradet, et al.
Research and Reports in Urology|June 4, 2014
IL-8 secretion in primary cultures of prostate cells is associated with prostate cancer aggressivenessBertrand Neveu, Xavier Moreel, Marie-Pier Deschênes-Rompré, et al.
Urology|August 11, 2004
uPM3, a new molecular urine test for the detection of prostate cancerYves Fradet, Fred Saad, Armen Aprikian, et al.
Pageof 24

Showing results (81-90 of 240) with videos related to

Sort By:
Pageof 24
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 1, 2014
Steroidogenic germline polymorphism predictors of prostate cancer progression in the estradiol pathwayEric Lévesque, Isabelle Laverdière, Etienne Audet-Walsh, et al.
Endocrine-Related Cancer|December 3, 2014
The UGT1 locus is a determinant of prostate cancer recurrence after prostatectomyIsabelle Laverdière, Christine Flageole, Étienne Audet-Walsh, et al.
The Prostate|January 27, 2004
Expression of p21 cell cycle protein is an independent predictor of response to salvage radiotherapy after radical prostatectomyJérôme Rigaud, Rabi Tiguert, Marc Decobert, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 5, 2008
Intravesical chemotherapy of high-grade bladder cancer with HTI-286, a synthetic analogue of the marine sponge product hemiasterlinBoris A Hadaschik, Hans Adomat, Ladan Fazli, et al.
European Urology|February 6, 2009
Bladder tumor infiltrating mature dendritic cells and macrophages as predictors of response to bacillus Calmette-Guérin immunotherapyCherifa Ayari, Hélène LaRue, Hélène Hovington, et al.
European Urology Focus|July 30, 2017
Metabolic Imaging of Prostate Cancer Reveals Intrapatient Intermetastasis Response Heterogeneity to Systemic TherapyFannie Morin, Jean-Mathieu Beauregard, Michelle Bergeron, et al.
European Urology|February 3, 2007
Tamoxifen as prophylaxis for prevention of gynaecomastia and breast pain associated with bicalutamide 150 mg monotherapy in patients with prostate cancer: a randomised, placebo-controlled, dose-response studyYves Fradet, Blair Egerdie, Morten Andersen, et al.
The Journal of Urology|May 15, 2007
A phase III, multicenter comparison of hexaminolevulinate fluorescence cystoscopy and white light cystoscopy for the detection of superficial papillary lesions in patients with bladder cancerH Barton Grossman, Leonard Gomella, Yves Fradet, et al.
Research and Reports in Urology|June 4, 2014
IL-8 secretion in primary cultures of prostate cells is associated with prostate cancer aggressivenessBertrand Neveu, Xavier Moreel, Marie-Pier Deschênes-Rompré, et al.
Urology|August 11, 2004
uPM3, a new molecular urine test for the detection of prostate cancerYves Fradet, Fred Saad, Armen Aprikian, et al.
Pageof 24